EMD-55340

Single-particle
2.61 Å
EMD-55340 Deposition: 10/10/2025
Map released: 25/03/2026
Last modified: 29/04/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-55340

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9sy5 summary report (pdf.gz) Map-9sy5 FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Engineering the ADDomer Nanoparticle Vaccine Scaffold for Improved Assembly and Enhanced Stability.

EMD-55340

Single-particle
2.61 Å
EMD-55340 Deposition: 10/10/2025
Map released: 25/03/2026
Last modified: 29/04/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Chimpanzee adenovirus Y25
Sample: CHIMPSELS S57C ADDomer: An engineered viral like particle derived from penton base protein of Chimpanzee adenovirus Y25.
Fitted models: 9sy5

Deposition Authors: Balchin G, Berger-Schaffitzel C, Berger I
Engineering the ADDomer Nanoparticle Vaccine Scaffold for Improved Assembly and Enhanced Stability.
PUBMED: 41840818
DOI: doi:10.1021/acssynbio.5c00757
ISSN: 2161-5063